VNDA

Vanda Pharmaceuticals Inc.

$6.45 -2.86%

Recent alerts on VNDA

All signals →

News Vanda (VNDA) Q2 Revenue Rises 4%

Short volume Short volume 70% of volume (3.1σ)

News Vanda targets $240M-$290M 2026 revenue as it introduces $10M-$30M NEREUS sales outlook

News Vanda rises after hours on launch of tradipitant for motion sickness

SEC filing VNDA Appoints Dr. Charles Duncan to Board, Expands to 7 Directors, Independent Count Rises to 6

Insider trade Sale by Mihael Hristos Polymeropoulos (President and CEO)

Insider trade Sale by Kevin Patrick Moran (SVP, CFO & Treasurer)

Insider trade Sale by Gunther Birznieks (SVP, Business Development)

Insider trade Sale by Timothy Williams (SVP & General Counsel)

Insider trade Sale by Joakim Wijkstrom (SVP, Chief Marketing Officer)

News Vanda granted public hearing to review FDA denying Hetlioz for jet lag

Scanner Unusual buy pressure (8.6x avg, 63% up-volume, +11.3% / +0.89 intraday, above VWAP)

News Vanda falls as FDA rejects jet lag drug

News Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder

News Vanda Pharmaceuticals price target raised to $14 from $11 at B. Riley

News Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness

News Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness

News Johnson & Johnson Wins FDA Nod For First Precision Combo For Mutated Prostate Cancer

News FDA Flags Medtronic Heart Catheter Recall As Most Serious Safety Risk

News Agios Pharmaceuticals stock soars after FDA approves AQVESME for thalassemia

News Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study

News Sanofi Makes $2.2 Billion Bet On Adult Vaccines With Dynavax Buy

News Sanofi to Buy Dynavax to Boost Vaccines Business

News Sanofi receives FDA complete response letter for MS drug tolebrutinib

News Agios Pharmaceuticals secures FDA approval for thalassemia treatment

Get push alerts for VNDA

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS